Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Role of Pirnas in Predicting and Prognosing in Cancer: A Focus on Pirna-823 (A Systematic Review and Meta-Analysis) Publisher Pubmed



Taghizadeh M1 ; Jafarikoshki T2 ; Jafarlou V3 ; Raeisi M4 ; Alizadeh L5 ; Roosta Y6, 7, 8 ; Matin S9 ; Jabari R12 ; Sur D10, 11 ; Karimi A1, 13
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Molecular Medicine, Faculty of Advanced Medical School, Tabriz University of Medical Sciences, Tabriz, 5166614756, Iran
  2. 2. Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, 5166616471, Iran
  3. 3. Cancer Institute of Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, 1419733141, Iran
  4. 4. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, 5166616471, Iran
  5. 5. Gastroenterology and Liver Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, 5166616471, Iran
  6. 6. Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, 5714783734, Iran
  7. 7. Solid Tumor Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, 5714783734, Iran
  8. 8. Hematology, Immune Cell Therapy, and Stem Cells Transplantation Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, 5714783734, Iran
  9. 9. Department of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, 8599156189, Iran
  10. 10. Department of Oncology, The Oncology Institute “Prof. Dr. Ion Chiricu¸ta�, Cluj-Napoca, 400015, Romania
  11. 11. Department of Medical Oncology, The Oncology Institute “Prof. Dr. Ion Chiricu ̧t ̆a�, 400015 Str. Republicii 34-36, Cluj-Napoca, 400006, Romania
  12. 12. Department of Nutrition Science, Faculty of Medical Science, Urmia University of Medical Science, Urmia, 5714783734, Iran
  13. 13. Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Golgasht St., East Azerbaijan, Tabriz, 5166614756, Iran

Source: BMC Cancer Published:2024


Abstract

Introduction: This article examines the potential of using liquid biopsy with piRNAs to study cancer survival outcomes. While previous studies have explored the relationship between piRNA expression and cancer patient outcomes, a comprehensive investigation is still lacking. To address this gap, we conducted a systematic review and meta-analysis of existing literature. Methods: We searched major online databases up to February 2024 to identify articles reporting on the role of piRNA in cancer patient survival outcomes. Our meta-analysis used a random-effects model to pool hazard ratios with 95% confidence intervals (CI) and assess the prognostic value of deregulated piRNA-823. For survival analysis, the Kaplan–Meier method and COX analysis were used. Results: Out of 6104 articles screened, 20 met our inclusion criteria. Our analysis revealed that dysregulated piRNA expression is associated with cancer patient survival outcomes. Specifically, our meta-analysis found that overexpression of piR-823 is significantly linked with poorer overall survival in patients with colorectal cancer and renal cell cancer (HR: 3.82, 95% CI = [1.81, 8.04], I2 = 70%). Conclusion: Our findings suggest that various piRNAs may play a role in cancer survival outcomes and that piRNA-823 in particular holds promise as a prognostic biomarker for multiple human cancers. Implications for cancer survivors: Our systematic review and meta-analysis of piRNA-823 has important implications for cancer survivors. Our findings suggest that piRNA-823 can be used as a prognostic biomarker for predicting cancer recurrence and survival rates. This information can help clinicians develop personalized treatment plans for cancer survivors, which can improve their quality of life and reduce the risk of recurrence. © The Author(s) 2024.
Related Docs
View other Related Docs
1. An Insight Into the Roles of Pirnas and Piwi Proteins in the Diagnosis and Pathogenesis of Oral, Esophageal, and Gastric Cancer, Pathology Research and Practice (2020)
2. Clinical Implications of Alu-Based Cell-Free Dna and Serum Onco-Pirna Monitoring in Colorectal Cancer Management, Clinical and Translational Oncology (2025)
3. The Function of Novel Small Non‐Coding Rnas (Pirnas, Trfs) and Piwi Protein in Colorectal Cancer, Cancer Treatment and Research Communications (2022)
4. Piwi-Interacting Rnas: New Biomarkers for Diagnosis and Treatment of Breast Cancer, Cell and Bioscience (2020)
5. Recent Advancements in Polyaniline-Based Biosensors for Diagnosis of Cancers: A Comprehensive Review, TrAC - Trends in Analytical Chemistry (2024)
6. Novel Perspectives for the Diagnosis and Treatment of Gynecological Cancers Using Dysregulation of Piwi Protein and Pirnas As Biomarkers, Current Medicinal Chemistry (2024)
7. The Promising Role of Non-Coding Rnas As Biomarkers and Therapeutic Targets for Leukemia, Genes (2023)
8. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Mansournia (2)
Mojgan Alaeddini (1)
Other Related Docs
9. The Potential of Pik3ca, Kras, Braf, and Apc Hotspot Mutations As a Non-Invasive Detection Method for Colorectal Cancer, Molecular and Cellular Probes (2022)
10. Liquid Biopsy and Its Significance on the Early Detection of Breast Cancer; [بیوپسی مایع و اهمیت آن در تشخیص زودهنگام سرطان پستان], Iranian Journal of Breast Diseases (2024)
11. Clinical Prognostic Value of the Smyd2/3 As New Epigenetic Biomarkers in Solid Cancer Patients: A Systematic Review and Meta-Analysis, Expert Review of Molecular Diagnostics (2022)
12. Tumor-Educated Platelets, Clinica Chimica Acta (2024)